Constellation Pharmaceuticals Competitors and Similar CompaniesClear all
Constellation Pharmaceuticals's competitors and similar companies include Imago BioSciences, Omega Therapeutics, Novartis and Hutchison China Meditech.
 Constellation Pharmaceuticals Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company that discovers and develops novel therapeutics that address serious unmet medical needs in patients with cancers. |  Imago BioSciences Imago BioSciences is a clinical-stage biotechnology company developing treatments for myeloid diseases. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Hutchison China Meditech Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products. | ||
Founding Date | Founding Date 2008 | Founding Date 2012 | Founding Date 2017 | Founding Date 1996 | Founding Date 2000 |
Type | Type Subsidiary | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ Boston, US | Locations Rahway, US HQ | Locations Cambridge, US HQ | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Shanghai, CN HQ Beijing, CN Jiangsu, CN Shanghai, CN Shanghai, CN Hong Kong, HK Hong Kong, HK see more |
Employees | Employees 474% decrease | Employees 2759% increase | Employees 60 | Employees 75,883 | Employees 1,811 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 68.4 m | Valuation ($) N/A | Valuation ($) 3.6 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $3.1m (FY, 2023) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $548.5m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $8.4b (FY, 2025) | Cost of goods $324.4m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $49.8b (FY, 2025) | Gross profit $224.2m (FY, 2025) |
Net income | Net income ($35.4m) (FY, 2017) | Net income ($42.3m) (FY, 2021) | Net income ($97.4m) (FY, 2023) | Net income $14b (FY, 2025) | Net income $435.1m (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 403.6m | Total funding raised $ 146.5m | Total funding raised $ 211m | Total funding raised $ 6.5m | Total funding raised $ 100m |
For sources of this data, please see the company profile
View Company Profiles
Imago BioSciences
HQ
Rahway, US
Imago BioSciences is a clinical-stage biotechnology company developing treatments for myeloid diseases.
View company
Omega Therapeutics
HQ
Cambridge, US
Employees
60
Omega Therapeutics is an epigenomic medicine company.
View companyNovartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyHutchison China Meditech
HQ
Shanghai, CN
Employees
1,811
Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products.
View company